AC
ALXO icon

Almitas Capital’s ALX Oncology ALXO Stock Holding History

Almitas Capital’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.08M Sell
2,938,431
-235,403
-7% -$421K 1.46% 16
2026
Q1 		$6.36M Buy
3,173,834
+636,943
+25% +$1.21M 1.44% 13
2025
Q4 		$2.87M Hold
2,536,891
– – 0.63% 31
2025
Q3 		$4.64M Sell
2,536,891
-1,464
-0.1% -$1.27K 1.06% 19
2025
Q2 		$1.05M Buy
2,538,355
+1,185,214
+88% +$598K 0.27% 45
2025
Q1 		$843K Buy
1,353,141
+130,196
+11% +$156K 0.28% 51
2024
Q4 		$2.04M Buy
+1,222,945
New +$1.88M 0.45% 36

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Almitas Capital's ALXO Position: Q2 2026 in Review

Almitas Capital reduced its ALX Oncology (ALXO) stake by 7.4% in Q2 2026, selling an estimated $421K and leaving 2,938,431 shares worth $6.08M. The position accounts for 1.46% of the portfolio, ranked #16.

Almitas Capital first reported a position in ALXO in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.36M in Q1 2026. 94 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Almitas Capital held 2,938,431 shares of ALX Oncology worth $6.08M as of Q2 2026.
  • Almitas Capital sold 235,403 ALX Oncology shares in Q2 2026, an estimated $421K.
  • ALX Oncology made up 1.46% of Almitas Capital's portfolio in Q2 2026, its #16 holding.
  • Almitas Capital first reported a position in ALX Oncology in Q4 2024 and has held it in 7 quarters since.
  • Almitas Capital's ALX Oncology position peaked at $6.36M in Q1 2026.
  • 94 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Almitas Capital's 13F filing for Q2 2026, filed 17 Aug 2026.